Signal transduction by receptors with tyrosine kinase activity

Cet article synthese montre comment des recepteurs membranaires a activite tyrosine kinase peuvent etre impliques dans la transduction et notamment jouent le role de signal de la transduction

[1]  A. Ullrich,et al.  A point mutation at the ATP‐binding site of the EGF‐receptor abolishes signal transduction. , 1988, The EMBO journal.

[2]  C. Heldin,et al.  Isoform‐specific induction of actin reorganization by platelet‐derived growth factor suggests that the functionally active receptor is a dimer. , 1989, The EMBO journal.

[3]  A. Ullrich,et al.  Release of a phorbol ester-induced mitogenic block by mutation at Thr-654 of the epidermal growth factor receptor , 1988, Molecular and cellular biology.

[4]  H. Wiley,et al.  Anomalous binding of epidermal growth factor to A431 cells is due to the effect of high receptor densities and a saturable endocytic system , 1988, The Journal of cell biology.

[5]  A. Ullrich,et al.  All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor. , 1989, The Journal of biological chemistry.

[6]  S. Singer,et al.  Identification of a developmentally regulated protein-tyrosine kinase by using anti-phosphotyrosine antibodies to screen a cDNA expression library. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Shier,et al.  Primary structure of a putative receptor for a ligand of the insulin family. , 1989, The Journal of biological chemistry.

[8]  G. Carpenter,et al.  Selectivity of phospholipase C phosphorylatiion by the epidermal growth factor receptor, the insulin receptor, and their cytoplasmic domains , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. M. Walton,et al.  Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation , 1989, Cell.

[10]  L. Cantley,et al.  The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase , 1989, Nature.

[11]  M. Roussel,et al.  Transforming potential of the c-fms proto-oncogene (CSF-1 receptor) , 1987, Nature.

[12]  A. Ullrich,et al.  Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization. , 1986, The EMBO journal.

[13]  J. Schlessinger,et al.  Signal transduction by allosteric receptor oligomerization. , 1988, Trends in biochemical sciences.

[14]  L. Rohrschneider,et al.  Activation of the feline c-fms proto-oncogene: Multiple alterations are required to generate a fully transformed phenotype , 1988, Cell.

[15]  D. Stern,et al.  Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo , 1988, Molecular and cellular biology.

[16]  L. Williams.  Signal transduction by the platelet-derived growth factor receptor. , 1989, Science.

[17]  E. L. Johnson,et al.  The protein-tyrosine kinase activity of the insulin receptor is necessary for insulin-mediated receptor down-regulation. , 1987, The Journal of biological chemistry.

[18]  H. Zahn,et al.  Hormone binding site of the insulin receptor: analysis using photoaffinity-mediated avidin complexing. , 1989, Biological chemistry Hoppe-Seyler.

[19]  Y. Yarden,et al.  Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. , 1987, Biochemistry.

[20]  A. Ullrich,et al.  Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity , 1988, Cell.

[21]  Y. Nishizuka,et al.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation , 1988, Nature.

[22]  C. Heldin,et al.  Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. , 1989, The Journal of biological chemistry.

[23]  J. Downing,et al.  Phospholipase C‐gamma, a substrate for PDGF receptor kinase, is not phosphorylated on tyrosine during the mitogenic response to CSF‐1. , 1989, The EMBO journal.

[24]  K. Siddle,et al.  Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. , 1989, The Biochemical journal.

[25]  M. Czech.  Signal transmission by the insulin-like growth factors , 1989, Cell.

[26]  T. Hunter,et al.  Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro , 1989, Cell.

[27]  A. Ullrich,et al.  HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. , 1989, The EMBO journal.

[28]  T. Fleming,et al.  PDGF induction of tyrosine phosphorylation of GTPase activating protein , 1989, Nature.

[29]  Waterfield,et al.  Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors. , 1989, Oncogene.

[30]  M. Rosenfeld,et al.  Alteration of epidermal growth factor receptor activity by mutation of its primary carboxyl-terminal site of tyrosine self-phosphorylation. , 1988, The Journal of biological chemistry.

[31]  A. Ullrich,et al.  Identification of autophosphorylation sites of HER2/neu. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[32]  G. M. Walton,et al.  Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies , 1988, Cell.

[33]  R. Davis,et al.  Activation of the epidermal growth factor receptor tyrosine protein kinase in the absence of receptor oligomerization. , 1988, The Journal of biological chemistry.

[34]  Y. Yarden,et al.  Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. , 1987, Biochemistry.

[35]  A. Ullrich,et al.  Functional analysis of the ligand binding site of EGF‐receptor utilizing chimeric chicken/human receptor molecules. , 1989, The EMBO journal.

[36]  A. Ullrich,et al.  Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Joseph L. Goldstein,et al.  Recycling receptors: The round-trip itinerary of migrant membrane proteins , 1983, Cell.

[38]  A. López-Rivas,et al.  Ca2+-mobilizing actions of platelet-derived growth factor differ from those of bombesin and vasopressin in Swiss 3T3 mouse cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[39]  R. Tsien,et al.  Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor , 1987, Nature.

[40]  V. Fried,et al.  Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. , 1989, Science.

[41]  A. Zilberstein,et al.  EGF induces tyrosine phosphorylation of phospholipase C-II: A potential mechanism for EGF receptor signaling , 1989, Cell.

[42]  A. Ullrich,et al.  Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing , 1987, Cell.

[43]  A. Ullrich,et al.  Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. , 1987, The Journal of biological chemistry.

[44]  A. Ullrich,et al.  Growth factor receptor tyrosine kinases. , 1988, Annual review of biochemistry.

[45]  A. Ullrich,et al.  Separate endocytic pathways of kinase-defective and -active EGF receptor mutants expressed in same cells , 1990, The Journal of cell biology.

[46]  P. Leder,et al.  Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.

[47]  T. Dull,et al.  A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. , 1987, The Journal of biological chemistry.

[48]  M. Jaye,et al.  Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[49]  A. Ullrich,et al.  Tyrosine kinase activity is essential for the association of phospholipase C-gamma with the epidermal growth factor receptor , 1990, Molecular and cellular biology.

[50]  A. Ullrich,et al.  Biological activities of EGF‐receptor mutants with individually altered autophosphorylation sites. , 1988, The EMBO journal.

[51]  A. Ullrich,et al.  Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[52]  A. Ullrich,et al.  An insertional mutant of epidermal growth factor receptor allows dissection of diverse receptor functions. , 1987, The EMBO journal.

[53]  I. Pastan,et al.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. , 1987, Science.

[54]  M. Schartl,et al.  Novel putative receptor tyrosine kinase encoded by the melanoma-inducing Tu locus in Xiphophorus , 1989, Nature.

[55]  A. Ullrich,et al.  A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis , 1987, Molecular and cellular biology.

[56]  J. Avruch,et al.  Relationship of site-specific beta subunit tyrosine autophosphorylation to insulin activation of the insulin receptor (tyrosine) protein kinase activity. , 1988, The Journal of biological chemistry.

[57]  A. Ullrich,et al.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells , 1987, Cell.

[58]  J. Downing,et al.  A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential , 1988, Cell.

[59]  J. Schlessinger,et al.  Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. , 1988, The Journal of biological chemistry.

[60]  A. Ullrich,et al.  Kinetic parameters of the protein tyrosine kinase activity of EGF‐receptor mutants with individually altered autophosphorylation sites. , 1988, The EMBO journal.

[61]  T. Pawson,et al.  The unique insert of cellular and viral fms protein tyrosine kinase domains is dispensable for enzymatic and transforming activities. , 1989, The EMBO journal.

[62]  Cori Bargmann,et al.  Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185 , 1986, Cell.

[63]  A. Ullrich,et al.  Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body , 1990, Cell.

[64]  D. Lowy,et al.  Functional heterogeneity of proto-oncogene tyrosine kinases: the C terminus of the human epidermal growth factor receptor facilitates cell proliferation. , 1989, Molecular and cellular biology.

[65]  M. Waterfield,et al.  Epidermal growth factor binding induces a conformational change in the external domain of its receptor. , 1989, The EMBO journal.

[66]  J. Pouysségur,et al.  Signal transduction in hamster fibroblasts overexpressing the human EGF receptor. , 1989, Growth factors.

[67]  P. Phillips,et al.  Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. , 1989, The Journal of biological chemistry.

[68]  M. Kraus,et al.  Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[69]  G. Carpenter,et al.  Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[70]  A. Ullrich,et al.  Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation of the EGF receptors in living cells , 1990, Molecular and cellular biology.

[71]  D. Weiner,et al.  A point mutation in the neu oncogene mimics ligand induction of receptor aggregation , 1989, Nature.

[72]  Jonathan A. Cooper,et al.  Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins , 1989, Cell.

[73]  T. Hunter,et al.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.

[74]  A. Ullrich,et al.  A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor , 1986, Nature.

[75]  J. Escobedo,et al.  A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGF , 1988, Nature.

[76]  R. Davis.  Independent mechanisms account for the regulation by protein kinase C of the epidermal growth factor receptor affinity and tyrosine-protein kinase activity. , 1988, The Journal of biological chemistry.

[77]  A. Ullrich,et al.  Cytoplasmic domains determine signal specificity, cellular routing characteristics and influence ligand binding of epidermal growth factor and insulin receptors. , 1989, The EMBO journal.

[78]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[79]  A. Ullrich,et al.  Differential signalling potential of insulin‐ and IGF‐1‐receptor cytoplasmic domains. , 1989, The EMBO journal.

[80]  D. Morrison,et al.  Direct activation of the serine/threonine kinase activity of raf-1 through tyrosine phosphorylation by the PDGF β-receptor , 1989, Cell.

[81]  A. Ullrich,et al.  Truncation of the human EGF receptor leads to differential transforming potentials in primary avian fibroblasts and erythroblasts. , 1988, The EMBO journal.

[82]  S. Rhee,et al.  Platelet-derived growth factor (PDGF) binding promotes physical association of PDGF receptor with phospholipase C. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[83]  A. Ullrich,et al.  Reconstitution of human epidermal growth factor receptors and its deletion mutants in cultured hamster cells. , 1986, The Journal of biological chemistry.

[84]  A. Ullrich,et al.  Intermolecular transphosphorylation between insulin receptors and EGF‐insulin receptor chimerae. , 1989, The EMBO journal.

[85]  R. Evans,et al.  Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms , 1986, Cell.

[86]  C. Norman.  A Close-Up Look at a Secret Soviet Radar: A visit by a congressional delegation to the infamous Krasnoyarsk radar indicates it would have little value in an ABM system, but probably violates the ABM treaty. , 1987, Science.